Baylor Sammons Cancer Center / Texas Oncology

Dallas, Texas 75246

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Renal Cell Carcinoma Clinical Trial
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)
Status: Enrolling, Phase III
Updated: 12/31/1969
Baylor Sammons Cancer Center / Texas Oncology
mi
from
Dallas, TX
Click here to add this to my saved trials